Merck shares fall on FDA drug rejection, Abbott shares rise
   
 
Home | Support
 
Headline News:
FDA
Fake Drugs
Drug Testing
 
 
Merck shares fall on FDA drug rejection, Abbott shares rise
29 Apr 08, 18:17
Merck & Co. shares fell Tuesday after the Food and Drug Administration rejected the drugmaker's cholesterol drug Cordaptive, marking the company's second drug application rejection in four days.
more

 

 
© 2007 nafdacnigeria.org